Yoğun Bakım Ünitesinde Hellp Sendromuna Yaklaşım
Özet
HELLP sendromu (Hemoliz, Elevated Liver enzymes, Low Platelet count), gebeliğin özellikle üçüncü trimesterinde veya postpartum dönemde görülen, maternal ve fetal morbidite ile mortaliteyi artıran ciddi bir obstetrik acil durumdur. Genellikle preeklampsi ile ilişkili olarak ortaya çıkar, ancak bazı olgularda preeklampsi bulgusu olmadan da gelişebilir. Tanı, laboratuvar parametrelerine dayanmakta olup; hemoliz, karaciğer enzimlerinde yükselme ve trombositopeni ile karakterizedir. Klinik spektrum oldukça değişken olup hafif vakalardan çoklu organ yetmezliğine kadar ilerleyebilen tablolara neden olabilir. Bu bölümde, postpartum dönemde gelişen ve çoklu organ disfonksiyonu ile seyreden Class 1 HELLP sendromu olgusu sunulmuştur. Hasta, sezaryen sonrası erken dönemde oligüri, ciddi trombositopeni, karaciğer enzimlerinde belirgin artış ve renal fonksiyon bozukluğu nedeniyle yoğun bakıma alınmıştır. İlk tedavilere yanıt alınamaması üzerine uygulanan plazmaferez ve hemodiyaliz tedavileri ile hastada klinik ve laboratuvar iyileşme sağlanmış, yoğun bakım süreci komplikasyonsuz tamamlanarak taburculuk gerçekleştirilmiştir. Bu olgu, şiddetli HELLP sendromu vakalarının yönetiminde multidisipliner yaklaşımın ve ileri organ destek tedavilerinin önemini vurgulamaktadır.
HELLP syndrome (Hemolysis, Elevated Liver enzymes, Low Platelet count) is a life-threatening obstetric emergency typically occurring during the third trimester or postpartum period. It is often associated with preeclampsia, although it may also develop independently. The diagnosis is based on laboratory findings, characterized by hemolysis, elevated liver enzymes, and thrombocytopenia. The clinical presentation can vary widely, ranging from mild symptoms to severe cases involving multi-organ dysfunction. In this chapter, we present a case of Class 1 HELLP syndrome that developed in the postpartum period and progressed to multi-organ failure. The patient was admitted to the intensive care unit (ICU) shortly after cesarean delivery due to oliguria, severe thrombocytopenia, marked elevation in liver enzymes, and acute renal impairment. As initial treatment modalities failed to stabilize her condition, plasmapheresis and hemodialysis were initiated, leading to significant clinical and laboratory improvement. The patient recovered without complications and was successfully discharged. This case emphasizes the importance of a multidisciplinary approach and advanced organ support therapies in managing severe HELLP syndrome.
Referanslar
Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol. 1982;142(2):159–167.
Wallace K, Harris S, Addison A, Bean C. HELLP Syndrome: Pathophysiology and Current Therapies. Curr Pharm Biotechnol. 2018;19(10):816–826.
Fitzpatrick KE, Hinshaw K, Kurinczuk JJ, Knight M. Risk factors, management, and outcomes of HELLP syndrome. Obstet Gynecol. 2014;123(3):618–627.
Conde-Agudelo A, Romero R. SARS-CoV-2 infection during pregnancy and risk of preeclampsia. Am J Obstet Gynecol. 2022;226(1):68–89.e3.
Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: clinical issues and management. BMC Pregnancy Childbirth. 2009;9:8.
Kirkpatrick CA. The HELLP syndrome. Acta Clin Belg. 2010;65(2):91–97.
Abildgaard U, Heimdal K. Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review. Eur J Obstet Gynecol Reprod Biol. 2013;166(2):117–123.
Burwick RM, Feinberg BB. Eculizumab for the treatment of preeclampsia/HELLP syndrome. Placenta. 2013;34(2):201–203.
Fonseca JE, Méndez F, Cataño C, Arias F. Dexamethasone treatment does not improve outcome in HELLP syndrome. Am J Obstet Gynecol. 2005;193(5):1591–1598.
Sibai BM. Imitators of severe preeclampsia. Obstet Gynecol. 2007;109(4):956–966.
Rao D, Chaudhari NK, Moore RM, Jim B. HELLP syndrome: a diagnostic conundrum with severe complications. BMJ Case Rep. 2016.
Lam MTC, Dierking E. Intensive Care Unit issues in eclampsia and HELLP syndrome. Int J Crit Illn Inj Sci. 2017;7(3):136–141.
McCormick PA, Higgins M, McCormick CA, et al. Hepatic infarction and rupture in HELLP syndrome. J Matern Fetal Neonatal Med. 2022;35(25):7942–7947.
Barton JR, Sibai BM. Diagnosis and management of HELLP syndrome. Clin Obstet Gynecol. 2004;47(4):956-962.
ACOG Practice Bulletin No. 222. Gestational Hypertension and Preeclampsia. Obstet Gynecol. 2020;135(6):e237-e260.
Hossain, M. A., et al. (2023). Role of Plasmapheresis in Hemolysis, Elevated Liver Enzymes and Low Platelets (HELLP) Syndrome. Cureus, 15(2), e35520.
https://doi.org/10.7759/cureus.35520
Martin JN Jr, Perry KG Jr, Roberts WE. Postpartum management of HELLP syndrome and eclampsia. Clin Obstet Gynecol. 1992;35(3):587-597.
Villar J, Say L, Shennan A. HELLP syndrome: pulmonary edema and ventilation strategies. Lancet. 2004;364(9442):1700-1702.
Brown MA, Magee LA, Kenny LC. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management. Pregnancy Hypertens. 2018;13:291–310.
McCormick PA, et al. Hepatic infarction and rupture in HELLP syndrome. J Matern Fetal Neonatal Med. 2022;35(25):7942–7947.
Ghukasyan NN, Gharibyan EE, et al. (2025). Pregnancy and delivery in the context of hemolytic uremic syndrome: A surrogacy case report. International Journal of Gynecology & Obstetrics. https://obgyn.onlinelibrary.wiley.com/doi/abs/10.1002/ijgo.70144
Inatomi A, Tokoro S, Katsura D, et al. (2025). The critical importance of diagnosing atypical hemolytic uremic syndrome in postpartum renal dysfunction in a patient with systemic lupus erythematosus: A case report and comprehensive review.
